Dolphin Medical Services (BOM:526504) Piotroski F-Score: 7 (As of Jun. 28, 2026) — 75% Above Median


BOM:526504 Dolphin Medical Services Ltd BOM:526504
36 GF Score
Price ₹8.69
GF Value ₹2.38
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Dolphin Medical Services Piotroski F-Score?

Dolphin Medical Services BOM:526504 36 Piotroski F-Score is 7 as of Jun. 28, 2026, which is 75% above its 10-year median of 4.00. GuruFocus rates BOM:526504 with a GF Score™ of 36/100 and a GF Value™ of ₹2.38 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 210 Medical Diagnostics & Research companies, Dolphin Medical Services ranks better than 94.29% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dolphin Medical Services has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Dolphin Medical Services's Piotroski F-Score or its related term are showing as below:

BOM:526504' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 7
Current: 7

During the past 13 years, the highest Piotroski F-Score of Dolphin Medical Services was 7. The lowest was 3. And the median was 4.

Dolphin Medical Services  (BOM:526504) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Dolphin Medical Services Piotroski F-Score Related Terms


Dolphin Medical Services Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Dolphin Medical Services's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolphin Medical Services Piotroski F-Score Chart

Dolphin Medical Services Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 5.00 4.00 4.00 7.00

Dolphin Medical Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 0.00 0.00 0.00 7.00

BOM:526504 vs TMO, DHR, IDXX: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Dolphin Medical Services's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolphin Medical Services Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dolphin Medical Services's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Dolphin Medical Services's Piotroski F-Score falls into.


BOM:526504
36GF Score
Dolphin Medical Services Ltd BOM:526504
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹0.42 Mil.
Cash Flow from Operations was ₹1.36 Mil.
Revenue was ₹7.50 Mil.
Gross Profit was ₹6.51 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (120.758 + 124.343) / 2 = ₹122.5505 Mil.
Total Assets at the begining of this year (Mar25) was ₹120.76 Mil.
Long-Term Debt & Capital Lease Obligation was ₹8.66 Mil.
Total Current Assets was ₹19.77 Mil.
Total Current Liabilities was ₹8.90 Mil.
Net Income was ₹-0.34 Mil.

Revenue was ₹7.79 Mil.
Gross Profit was ₹6.64 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (121.324 + 120.758) / 2 = ₹121.041 Mil.
Total Assets at the begining of last year (Mar24) was ₹121.32 Mil.
Long-Term Debt & Capital Lease Obligation was ₹8.66 Mil.
Total Current Assets was ₹19.77 Mil.
Total Current Liabilities was ₹5.76 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dolphin Medical Services's current Net Income (TTM) was 0.42. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Dolphin Medical Services's current Cash Flow from Operations (TTM) was 1.36. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=0.419/120.758
=0.00346975

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-0.338/121.324
=-0.00278593

Dolphin Medical Services's return on assets of this year was 0.00346975. Dolphin Medical Services's return on assets of last year was -0.00278593. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Dolphin Medical Services's current Net Income (TTM) was 0.42. Dolphin Medical Services's current Cash Flow from Operations (TTM) was 1.36. ==> 1.36 > 0.42 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=8.664/122.5505
=0.07069739

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=8.664/121.041
=0.07157905

Dolphin Medical Services's gearing of this year was 0.07069739. Dolphin Medical Services's gearing of last year was 0.07157905. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=19.768/8.895
=2.22237212

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=19.768/5.762
=3.43075321

Dolphin Medical Services's current ratio of this year was 2.22237212. Dolphin Medical Services's current ratio of last year was 3.43075321. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Dolphin Medical Services's number of shares in issue this year was 15.1. Dolphin Medical Services's number of shares in issue last year was 16.9. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6.512/7.501
=0.86815091

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=6.638/7.794
=0.85168078

Dolphin Medical Services's gross margin of this year was 0.86815091. Dolphin Medical Services's gross margin of last year was 0.85168078. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=7.501/120.758
=0.06211597

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=7.794/121.324
=0.06424121

Dolphin Medical Services's asset turnover of this year was 0.06211597. Dolphin Medical Services's asset turnover of last year was 0.06424121. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Dolphin Medical Services has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Dolphin Medical Services (BOM:526504) has a Piotroski F-Score of 7 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dolphin Medical Services and its competitors. This is 75% above median its historical median of 4.00. Over the past decade, Dolphin Medical Services' Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Dolphin Medical Services ranks #12 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 5.7%.
Is Dolphin Medical Services' Piotroski F-Score too high?
Dolphin Medical Services' current Piotroski F-Score of 7 is 75% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Dolphin Medical Services' value of 7 is 40% above this industry median. Based on the distribution chart, Dolphin Medical Services ranks #12 out of 210 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Dolphin Medical Services has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dolphin Medical Services' Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Dolphin Medical Services ranks #12 out of 210 companies for Piotroski F-Score. This places Dolphin Medical Services in the top 6% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Dolphin Medical Services' value of 7 is 40% above this benchmark. Historically, Dolphin Medical Services' own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Dolphin Medical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dolphin Medical Services's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Dolphin Medical Services and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dolphin Medical Services's current Piotroski F-Score is 7, which is 75% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolphin Medical Services stock overvalued right now?
Based on GuruFocus' analysis, Dolphin Medical Services (BOM:526504) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.38, compared to a current price of ₹8.69 — trading 265.1% above its estimated fair value. The current Piotroski F-Score is 7, which is 75% above median its 10-year median of 4.00 and 40% above the Medical Diagnostics & Research industry median of 5.00. Dolphin Medical Services' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Dolphin Medical Services (BOM:526504), the current Piotroski F-Score is 7 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolphin Medical Services (BOM:526504) Overvalued in 2026?

Based on GuruFocus' analysis, Dolphin Medical Services stock appears to be overvalued. The current stock price of ₹8.69 is trading 265.1% above its estimated GF Value™ of ₹2.38. GuruFocus considers Dolphin Medical Services to be Significantly Overvalued.

Key valuation signals for BOM:526504:

  • Piotroski F-Score: 7 (75% above median its 10-year median of 4.00)
  • GF Value™: ₹2.38 vs. price of ₹8.69 (265.1% above fair value)
  • GF Score™: 36/100 with 5 warning signs
  • Industry Position: 40% above the Medical Diagnostics & Research median (#12 of 210)

No single metric tells the full story. See the BOM:526504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dolphin Medical Services Business Description

Address Kovelamudivari Veedhi, D.No.29-28/1-27, Suryaraopet, Vijayawada, AP, IND, 520002
Dolphin Medical Services Ltd is engaged in providing diagnostics and other allied services. It includes a range of tests covering radiology and imaging, biochemistry, pathology, and microbiology. In addition, the company is also involved in Information Technology, Biotechnology, and Herbal sectors. Services provided by the company are Diagnostic Centre provides all the services under one roof; the Ophthalmic Laser Care Centre provides total laser eye treatment as "Dolphin Nethralaya"; Teleradiology Services; Clinical Trials and Life Sciences division; Medical Equipment & Goods associated distribution; Bio-Tech Division is to provide Foods and Herbal Products and Dolphin Electronic Solution and Technologies(DEST).
36GF Score

Get the complete analysis for BOM:526504

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.69
Price
₹2.38
GF Value